MALAT1 |
Upregulated |
Enhances the expression and release of inflammatory mediators; modulates cellular responses like pyroptosis and apoptosis |
Modulates NF-κB, TLR4, Wnt/β-catenin, PI3K/Akt/mTOR; acts as a ceRNA interacting with miR-146a, miR-145, miR-9; affects cytokine release, ECM degradation, and cell proliferation. |
[91–96] |
PVT1 |
Upregulated |
Promotes inflammatory responses, ECM degradation, and chondrocyte apoptosis. |
Influences TLR4/NF-κB TGF-β/SMAD4 pathways; acts as a ceRNA; targets such as miR −146a, miR-93-5p, miR-27b-3p, miR-140, miR-211-3p influencing MMP and cytokine levels. |
[100–102,104,105,107] |
H19 |
Upregulated |
Enhance the release of inflammatory cytokines, affect the vitality and proliferation of chondrocytes, and promote angiogenesis |
Regulates pathways like NF-κB, TLR4, JNK and AKT; interacts with miR-106a-5p, miR130a, miR-103a affecting cytokine levels and ECM components. |
[113–116,118] |
HOTAIR |
Upregulated |
Contributes to chondrocyte apoptosis and inflammatory responses. |
Regulates pathways like NF-κB/TNFα, MAPK/c-Jun; modulates miRNA function impacting inflammatory signaling and ECM degradation such as miR-1277-5P, miR-107, miR-222-3p, miR-17-3p |
[123,125–128] |
NEAT1 |
Upregulated |
Targets miRNAs to regulate inflammation and apoptosis in chondrocytes. |
Involves Wnt/β-catenin and NF-κB pathways; interacts with miRNAs like miR-543, miR-146a-3p, miR-193a-3p, miR-16-5p affecting inflammation-related gene expression. |
[120,130,131,133–136] |
THRIL |
Upregulated |
Promotes inflammation and chondrocyte apoptosis, exacerbates inflammatory injury. |
Modulates JAK1/STAT3, NF-κB, PI3K/AKT pathways; influences cytokine production and cellular viability. |
[139,140] |
XIST |
Upregulated |
Regulates gene expression related to inflammation and chondrocyte viability. |
Acts as a ceRNA for miR-149-5p, miR-376c-5p; interacts with pathways like PI3K/Akt and affects cytokine levels and ECM components. |
[142–144] |
MEG3 |
Downregulated |
Plays a role in reducing inflammatory responses, chondrocyte apoptosis and reduces angiogenesis. |
Regulation of miR-16, miR-93 and other miRNAs; It affects TGF-β, TLR4/ NF-κB pathway and ECM degradation |
[146,150,151,153,155,156] |
GAS5 |
Downregulated |
Inhibits chondrocyte apoptosis and modulates inflammatory responses. |
Functions as a ceRNA for miR-146a; impacts Smad4 expression and inflammatory signaling pathways. |
[158–160] |
NKILA |
Downregulated |
Inhibit the activation of NF-κB, reduce the expression of inflammatory mediators and angiogenesis |
Stabilizes the NF-κB/IκB complex; modulates inflammation and cellular responses in chondrocytes. |
[162–164] |
ATB |
Downregulated |
Reduces inflammatory mediators and promotes chondrocyte viability. |
Regulates Akt phosphorylation; affects MyD88 and p38 in the TLR4/NF-κB and MAPK pathways. |
[166,167] |
PACER |
Downregulated |
Modulates affecting inflammatory responses and cartilage degeneration. |
Interacts with NF-κB p50 subunit |
[169] |
OIP5-AS1 |
Downregulated |
Mitigates inflammatory responses and promotes chondrocyte viability. |
Regulates PI3K/AKT pathway, AMPK/Akt/mTOR; interacts with miR-338-3p affecting cytokine expression and ECM integrity. |
[173–175] |